Company profile for Diagonal Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Diagonal Therapeutics is a trailblazing biotech firm revolutionizing the discovery and development of agonist antibodies. Leveraging our proprietary DIAGONAL platform, we integrate cutting-edge computational and experimental methods to overcome longstanding obstacles in agonist antibody drug discovery. Our burgeoning pipeline, crafted through the DIAGONAL platform, holds promise in delivering transformative treatments to patie...
Diagonal Therapeutics is a trailblazing biotech firm revolutionizing the discovery and development of agonist antibodies. Leveraging our proprietary DIAGONAL platform, we integrate cutting-edge computational and experimental methods to overcome longstanding obstacles in agonist antibody drug discovery. Our burgeoning pipeline, crafted through the DIAGONAL platform, holds promise in delivering transformative treatments to patients, including therapies tailored for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Floor 8, Cambridge, MA 02139
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/04/3199709/0/en/Diagonal-Therapeutics-to-Present-Insights-from-HHT-IMPACT-a-Natural-History-Study-Initiated-in-Partnership-with-Cure-HHT-at-ASH-2025.html

GLOBENEWSWIRE
04 Dec 2025

https://www.globenewswire.com/news-release/2025/07/10/3113099/0/en/Diagonal-Therapeutics-Announces-Publication-of-Data-Characterizing-the-Healthcare-System-Cost-and-Impact-of-Hereditary-Hemorrhagic-Telangiectasia-HHT-in-the-American-Journal-of-Hem.html

GLOBENEWSWIRE
10 Jul 2025

https://www.globenewswire.com/news-release/2025/07/08/3111593/0/en/Diagonal-Therapeutics-Appoints-John-Lee-M-D-Ph-D-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
08 Jul 2025

https://www.globenewswire.com/news-release/2025/06/18/3101304/0/en/Diagonal-s-First-in-Class-Clustering-Antibody-DIAG723-Receives-Orphan-Drug-Designation-ODD-from-U-S-FDA-and-an-ODD-Positive-Opinion-from-EMA-for-Treatment-of-Hereditary-Hemorrhagic.html

GLOBENEWSWIRE
18 Jun 2025

https://www.globenewswire.com/news-release/2025/06/12/3098057/0/en/Diagonal-Therapeutics-to-Present-New-Preclinical-Data-Demonstrating-Disease-Modifying-Potential-of-Receptor-Clustering-Antibody-Approach-in-HHT-at-EHA-2025-Congress.html

GLOBENEWSWIRE
12 Jun 2025

https://www.globenewswire.com//news-release/2025/03/04/3036355/0/en/Diagonal-Therapeutics-Initiates-Natural-History-Study-of-Adults-Living-with-Hereditary-Hemorrhagic-Telangiectasia-HHT-a-Rare-Bleeding-Disorder-with-No-Approved-Treatments.html

GLOBENEWSWIRE
04 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty